Pills from vitiligo (Baidianfeng Wan)
Effect of the drug:
It promotes cures vitiligo,
quickly relieves itching,
nourishing blood, removes blood stasis and qi, stimulates circulation, promotes detoxification,
promotes urination, it eliminates bruising,
significantly enhances tyrosinase activity to accelerate the synthesis of melanin from melanocytes,
improve the blood circulation in areas of white spots,
restore damaged skin cells,
improve skin photosensitivity.
Indications: treatment of vitiligo.
Ingredients: psoralea leschinolistnaya, astragalus Juancho, safflower, ligustikum Wallich, angelica kitaysky root Cyperus, the core peach seed, sage mnogokornevischny, vityazhka rat snake, lithospermum krasnokornevoy bark yasentsa rhizome discoria Chinese, dried wheat, gentian rough, Tribulus terrestris.
Method of application: oral, 6 pipyul 2 times daily or according to doctor's orders.
Side effects: Unknown.
Storage: Keep in a sealed container in a dry place.
Tags: Treatment of skin diseases |
Pills from vitiligo (Baidianfeng Wan) - preparation of Chinese medicine for the treatment of vitiligo.
Appointment of the drug: the treatment of vitiligo, reducing itching in vitiligo, blood detoxification, improves the activity of tyrosinase, to accelerate the synthesis of melanin from melanocytes, improve blood circulation in areas of white spots, restore damaged skin cells, improve skin photosensitivity.
Pills are rich in trace elements comprise copper, iron, zinc, manganese ions whose closely associated with the disease
During the administration of the drug in some patients can be drowsy, possible symptoms of fever.
The current standard: State drug quality standard of China, that is 15, quality standard LAN № WS3 - B - 2868 - 98..
ratification Number: Medical License Z22020393.
Attention! The drug sold rate - 5 of packages within a package 30 pills.
Manufacturer: Pharmaceutical company Innuoke Jilin Province (Jilin YinNuoKe Pharmaceutical Co., Ltd), Str. Sinfudun, 999, Economic Development Zone Chzhenlay County, prov. Jilin, China.